Dynavax Technologies (NASDAQ:DVAX) reported quarterly earnings of $0.02 per share which beat the analyst consensus estimate of $(0.04) by 150 percent. This is a 103.77 percent increase over losses of $(0.53) per share from the same period last year. The company reported quarterly sales of $52.77 million which beat the analyst consensus estimate of $41.59 million by 26.87 percent. This is a 1.88K percent increase over sales of $2.67 million the same period last year.
Dynavax Technologies Q2 EPS $0.02 Beats $(0.04) Estimate, Sales $52.77M Beat $41.59M Estimate
Dynavax Technologies (NASDAQ:DVAX) reported quarterly earnings of $0.02 per share which beat the analyst consensus estimate of $(0.04) by 150 percent. This is a 103.77 percent increase over losses of $(0.53) per share
